Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production
- PMID: 10662619
- DOI: 10.1006/viro.1999.0111
Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production
Abstract
Susceptibility of PHA/rIL-2-stimulated PBMC from 14 healthy blood donors for NSI HIV-1 infection was analyzed in relation to CCR5 expression and beta-chemokine production. After 1 week of culture in the presence of rIL-2, but not at the moment of inoculation, CCR5 surface expression was positively and beta-chemokine production was inversely associated with susceptibility to NSI HIV-1 infection. Surprisingly, no association was observed between CCR5 genotype and in vitro NSI HIV-1 susceptibility, which was in agreement with similar levels of CCR5 surface expression and beta-chemokine production in CCR5Delta32/+ and CCR5 +/+ PBMC after PHA/rIL-2 stimulation. In contrast to what was observed in vitro, CCR5 genotype did associate with CCR5 surface expression levels in vivo in resting as well as in activated CD4(+) T cell populations that were identified by the expression of CD45RO, CD27, HLA-DR, and CD69. The association between CCR5 expression and susceptibility to infection by NSI HIV-1 observed in vitro might offer an explanation for the in vivo observed protective effect of CCR5 polymorphisms that influence CCR5 expression on disease progression.
Copyright 2000 Academic Press.
Similar articles
-
Increased CCR5 expression with decreased beta chemokine secretion in Ethiopians: relevance to AIDS in Africa.J Hum Virol. 1999 Sep-Oct;2(5):283-9. J Hum Virol. 1999. PMID: 10551734
-
IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.J Leukoc Biol. 2002 Oct;72(4):735-42. J Leukoc Biol. 2002. PMID: 12377943
-
Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.Virology. 1998 Apr 25;244(1):66-73. doi: 10.1006/viro.1998.9082. Virology. 1998. PMID: 9581779
-
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE).J Hum Virol. 2000 Jan-Feb;3(1):44-9. J Hum Virol. 2000. PMID: 10774806 Clinical Trial.
-
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box.Int J Immunogenet. 2020 Jun;47(3):261-285. doi: 10.1111/iji.12485. Epub 2020 Mar 24. Int J Immunogenet. 2020. PMID: 32212259 Review.
Cited by
-
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs.Semin Immunol. 2021 Jan;51:101438. doi: 10.1016/j.smim.2020.101438. Epub 2020 Nov 30. Semin Immunol. 2021. PMID: 33272901 Free PMC article. Review.
-
CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships.Immunology. 2017 Aug;151(4):464-473. doi: 10.1111/imm.12743. Epub 2017 May 24. Immunology. 2017. PMID: 28398593 Free PMC article.
-
Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies.Retrovirology. 2014 Jun 23;11:48. doi: 10.1186/1742-4690-11-48. Retrovirology. 2014. PMID: 24957778 Free PMC article.
-
Affinofile profiling: how efficiency of CD4/CCR5 usage impacts the biological and pathogenic phenotype of HIV.Virology. 2013 Jan 5;435(1):81-91. doi: 10.1016/j.virol.2012.09.043. Virology. 2013. PMID: 23217618 Free PMC article. Review.
-
The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.BMC Infect Dis. 2014 Dec 13;14:683. doi: 10.1186/s12879-014-0683-0. BMC Infect Dis. 2014. PMID: 25495598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
